Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06414395
PHASE4

The Effects of Different Loading Doses of Dexmedetomidine on The Bispectral Index-Guided Propofol Sedation in Patients Undergoing Advanced Upper Gastrointestinal Endoscopic Procedures: A Randomized Control Study

Sponsor: Theodor Bilharz Research Institute

View on ClinicalTrials.gov

Summary

Propofol is currently the most common drug used but has drawbacks like narrow therapeutic window and potential complications. Dexmedetomidine is an attractive alternative due to its unique properties like minimal respiratory depression. Studies are ongoing to find the optimal use of dexmedetomidine for these procedures. A combination of propofol and dexmedetomidine might be ideal, but the best balance between the two drugs needs further investigation.

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

52

Start Date

2024-05-01

Completion Date

2024-10-01

Last Updated

2024-05-16

Healthy Volunteers

No

Interventions

DRUG

Precedex (Dexmedetomidine) 200 MCG in 2 ML Injection

The Effects of Different Loading Doses of Dexmedetomidine on The Bispectral Index-Guided Propofol Sedation in Patients Undergoing Advanced Upper Gastrointestinal Endoscopic Procedures: A Randomized Control Study

OTHER

C group: Patients received saline infusion over 10 minutes

the group will receive normal saline infusion over 10 minutes.

Locations (1)

Theodor Bilharz Research Institute

Cairo, Giza Governorate, Egypt